Myofunctional therapy for children with obstructive sleep apnea
Official title: Myofunctional Therapy for Children With Obstructive Sleep Apnoea - a Multi-centre Randomised Controlled Trial
Run by Chinese University of Hong Kong · NCT07249944 · Data updated 2026-11-12
This study tests whether myofunctional therapy helps children aged 6–12 who have obstructive sleep apnea see improvements in sleep and breathing.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 12 Years |
| Sex | All |
| Enrollment | 174 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Shatin) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | October 21, 2026 |
| Trial ID | NCT07249944 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 6–12 years with clinically diagnosed OSA confirmed by polysomnography (oAHI ≥ 1/hour).
✕Probably not a fit
Some children may not respond to myofunctional therapy or may have OSA primarily driven by factors not addressed by MFT.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized study investigates the efficacy of myofunctional therapy as an adjunct treatment for pediatric obstructive sleep apnea. Eligible children aged 6–12 with diagnosed OSA will receive structured myofunctional exercises, with outcome measures including sleep parameters and airway function. The trial builds on limited prior evidence from smaller studies and seeks to provide more robust data, including the potential role of remote guidance. The study aims to address gaps such as follow-up duration and the effect on craniofacial structure. It is conducted under the auspices of the Chinese University of Hong Kong and collaborating Hong Kong hospitals.
Why it matters
Potential benefit: If successful, children may experience better sleep quality and reduced airway obstruction related to OSA.
How similar studies have gone: Previous small studies and case-control data suggested improvement with MFT, but high-quality randomized trials are limited; this trial seeks to provide clearer evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Children aged 6-12 years, with this age range, children start to have a greater ability to understand and follow instructions, making them more likely to comply and cooperate with the treatment procedures, and at the same time this age range remains a critical and modifiable developmental window when interventions can address underlying orofacial muscle and respiratory muscle dysfunctions and enhance the potential for long-term benefits. 2. Diagnosed with OSA based on clinical evaluation and polysomnography (oAHI ≥ 1/hour). The clinical evaluation will involve assessing the presence of habitual snoring, which is defined as snoring occurring 3 nights or more per week on average as reported by parents or caregivers, and any of the following features suggestive of SDB such as oral breathing, respiratory pauses, observed apnoeas, or increased work of breathing during sleep. Children with persistent OSA, documented by repeat PSG, can be included after receiving standard treatments (such as adenotonsillectomy treatment). 3. Informed consent from a parent or a legal guardian. Exclusion Criteria: * Genetic, syndromal, or metabolic disease * Congenital or acquired neuromuscular disease * Syndromal craniofacial abnormalities or previous craniofacial surgery * Severe developmental delay (developmental or functional age \<66% of chronological age) * Children with OSA who are indicated for and will receive other treatments such as adenotonsillectomy, positive airway pressure therapy or orthodontic treatment.
Where it's running
-
Prince of Wales Hospital, The Chinese University of Hong Kong
Shatin, Hong Kong Recruiting
Study contacts
- Principal investigator: Ching Ching, Kate CHAN, MD — Chinese University of Hong Kong
- Study coordinator: Ching Ching, Kate CHAN, MD
- Email: katechan@cuhk.edu.hk
- Phone: (852) 3505 3515
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
F&P Mask usability in home PAP/NIV care for adults with chronic breathing conditions
This study tests how well the F&P Licorice Mask works at home for adults who already use PAP or NIV therapy.
-
Sleep apnea biomarkers and CPAP use after diagnosis
This study tests whether biomarkers from a diagnostic sleep study can predict how well adults with newly diagnosed obstructive sleep apnea will stick to CPAP therapy after about 3 months.
-
Using the PLATO Questionnaire in Oral Appliance Therapy for Obstructive Sleep Apnea
This real-world study tests whether the PLATO questionnaire can be feasibly used in dental sleep clinics for patients receiving oral appliance therapy for obstructive sleep apnea.
-
Managing COMISA: adding daridorexant to CPAP may help sleep and CPAP use
This study tests whether adding daridorexant to CPAP helps people with COMISA better stick with CPAP and feel better.
-
OSA Screening in Diverse Populations
This study tests how common obstructive sleep apnea is across community members and people with certain diseases in China, using screening questionnaires and polysomnography or portable sleep monitors.
-
Wall Squat Exercise to Help Lower Blood Pressure in Adults with Hypertension and Sleep Apnea
This study tests whether doing an isometric wall squat can lower blood pressure in adults who have high blood pressure and sleep apnea treated with CPAP.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.